The launch of this new, longer-wear device is a key part of the company's product roadmap to improve user convenience and defend market share, triggering significant spending on go-to-market activities, sales training, and inventory management.
Filing excerpt
We launched our latest generation systems, the Dexcom G7 Continuous Glucose Monitoring System, or G7, in 2023, and the Dexcom G7 15 Day Continuous Glucose Monitoring System, or G7 15 Day, in late 2025.
What this signalsFilings often name leadership changes, deals and spending plans.
Regions named
sec-10kproductLaunchGet every 10-K signal for Dexcom and the companies you sell to, in the tools you already use.
Connect Autobound to Claude, Claude Code or Cursor with MCP. Then ask: “What changed at Dexcom this week?”
The Signal API returns 10-K signals for any list of companies as JSON, for your CRM, warehouse or app.
Sign up and spend your free credits on the companies you sell to.
This page shows a preview. The full sec-10k record in the Signal API and MCP can also have these 8 fields. Some fields are empty for some signals.
Company
linkedin_urlValue in the APIindustriesValue in the APIemployee_count_lowValue in the APIemployee_count_highValue in the APIrevenueValue in the APIdescriptionValue in the APISignal
signal_nameValue in the APIassociationValue in the APIGET /v1/signals/854a3948-3bc1-4506-9b28-94e47dca193c returns this record as JSON. POST /v1/companies/enrich returns every signal for dexcom.com.
{
"signal_id": "854a3948-3bc1-4506-9b28-94e47dca193c",
"signal_type": "sec-10k",
"signal_subtype": "productLaunch",
"detected_at": "2026-02-17T06:33:02.596+00:00",
"company": {
"name": "Dexcom",
"domain": "dexcom.com"
},
"data": {
"detail": "The launch of this new, longer-wear device is a key part of the company's product roadmap to improve user convenience and defend market share, triggering significant spending on go-to-market activities, sales training, and inventory management.",
"metrics": {
"timeframe": "current_year"
},
"summary": "Dexcom launched its new G7 15 Day CGM system in late 2025 after receiving FDA approval",
"excerpts": "We launched our latest generation systems, the Dexcom G7 Continuous Glucose Monitoring System, or G7, in 2023, and the Dexcom G7 15 Day Continuous Glucose Monitoring System, or G7 15 Day, in late 2025.",
"relevance": 0.9,
"sentiment": "positive",
"confidence": "high",
"source_url": "https://www.sec.gov/Archives/edgar/data/1093557/000109355726000027/dxcm-20251231.htm",
"filing_date": "2026-02-12",
"filing_year": 2026,
"fiscal_year_end": "12/31",
"sales_relevance": "Go-to-market support",
"signal_category": "strategic",
"regions_mentioned": [
"United States"
]
}
}
curl https://signals.autobound.ai/v1/signals/854a3948-3bc1-4506-9b28-94e47dca193c \
-H "X-API-KEY: $AUTOBOUND_API_KEY"curl -X POST https://signals.autobound.ai/v1/companies/enrich \
-H "X-API-KEY: $AUTOBOUND_API_KEY" \
-H "Content-Type: application/json" \
-d '{"domain":"dexcom.com","limit":20}'Long text fields are shortened on this page.
Looking up one signal by its id is free. Enrich costs 2 credits per signal returned; a call with no results is free.